A detailed history of Picton Mahoney Asset Management transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Picton Mahoney Asset Management holds 11 shares of LGND stock, worth $1,183. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11
Holding current value
$1,183
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Apr 02, 2025

BUY
$99.95 - $129.9 $1,099 - $1,428
11 New
11 $1,000

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.82B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Picton Mahoney Asset Management Portfolio

Follow Picton Mahoney Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Picton Mahoney Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Picton Mahoney Asset Management with notifications on news.